Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
AB ›
ABYXXIO
Trademark search for:
ABYXXIO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-10-05 — Application filed
2020-10-08 — Application filed
2020-11-19 — Application filed
2021-02-02 — Assigned to examiner
2021-02-03 — Final disposition recorded
2021-02-03 — Final disposition recorded
2021-02-03 — Final disposition recorded
2021-07-20 — Office action issued
2021-07-20 — Correspondence received in law office
2021-07-21 — Teas/email correspondence entered
2021-07-26 — Approved for pub - principal register
2021-08-11 — Notification of notice of publication e-mailed
2021-08-31 — Published for opposition
2021-08-31 — Official gazette publication confirmation e-mailed
2021-10-26 — Noa e-mailed - sou required from applicant
2022-04-18 — Sou teas extension received
2022-04-18 — Sou extension 1 filed
2022-04-18 — Sou extension 1 granted
2022-04-20 — Notice of approval of extension request e-mailed
2022-10-04 — Sou teas extension received
2022-10-04 — Sou extension 2 filed
2022-10-04 — Sou extension 2 granted
2022-10-06 — Notice of approval of extension request e-mailed
2023-03-22 — Sou teas extension received
2023-03-22 — Sou extension 3 filed
2023-03-22 — Sou extension 3 granted
2023-03-24 — Notice of approval of extension request e-mailed
2023-10-23 — Sou teas extension received
2023-10-23 — Sou extension 4 granted
2023-10-23 — Sou extension 4 filed
2023-10-25 — Notice of approval of extension request e-mailed
2024-04-18 — Sou teas extension received
2024-04-18 — Sou extension 5 filed
2024-04-18 — Sou extension 5 granted
2024-04-19 — Notice of approval of extension request e-mailed
2024-12-02 — Application abandoned
2024-12-02 — Application abandoned
2024-12-02 — Final status recorded
Owner Information
ADC Therapeutics SA
Epalinges CH
ADC Therapeutics SA
Epalinges CH
Correspondent
Tracy-Gene G. Durkin Sterne, Kessler, Goldstein & Fox P.L.L.C. 1101 K Street, NW 10th Floor WASHINGTON, DC 20005
Filing Details
Filing Date:
2020-10-05
Status Date:
2024-12-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.